Clinical significance of the low expression of FER1L4 in gastric cancer patients. - Wikidata - awgldk - TriplyDB

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

http://www.wikidata.org/entity/Q43653975

about

Circulating long non-coding RNAs in cancer: current status and future perspectives Long noncoding RNAs in gastric cancer: functions and clinical applications Molecular mechanisms of long noncoding RNAs on gastric cancer Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications Emerging blood-based biomarkers for detection of gastric cancer Dysregulation of non-coding RNAs in gastric cancer Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker A meta-analysis: The diagnostic values of long non-coding RNA as a biomarker for gastric cancer.Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.LncRNAs: From Basic Research to Medical Application Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studies.LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer.Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer Plasma lncRNA-GACAT2 is a valuable marker for the screening of gastric cancer.Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances.Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.Long noncoding RNAs in gastric cancer carcinogenesis and metastasis.Roles of long noncoding RNAs in gastric cancer and their clinical applications.Pseudogenes in gastric cancer pathogenesis: a review article.Clinicopathological features of gastric adenocarcinoma patients with metachronous distant metastasis.LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer.The role of miRNA and lncRNA in gastric cancer.Post-transcriptional Regulation of Genes Related to Biological Behaviors of Gastric Cancer by Long Noncoding RNAs and MicroRNAs.Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma.Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis.Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.Liquid biopsy provides new insights into gastric cancer.Clinical significance of the long noncoding RNA RP11-19P22.6-001 in gastric cancer.Long non-coding RNAs involved in metastasis of gastric cancer

P2860

Q26748862-F96FE10D-ADB2-4DDA-B6B0-46E503217475 Q26765291-5F1190F1-52A6-446C-8BE9-51F18E675648 Q26770685-ECE48C04-6F87-47DB-8F1F-599C07E4C767 Q26774498-3B687733-EEB7-4590-A996-E248ACE8EA8C Q26778026-ECC96978-1129-4642-BAC7-114AF770B9AA Q26780293-97BC4E06-9152-4A5F-B3F6-F6D077EA5485 Q26785539-188B8C39-08B4-4D96-8497-69C6C842BD3C Q26996377-733498D8-876F-4BF3-9734-310606A35BF4 Q28088454-6B6FB973-B812-4970-8F08-C1F533D81004 Q28088492-5E7E6579-CF0C-487E-943E-605DED38A35E Q33748354-332685F4-F461-47B6-A873-3B1F90595DB3 Q35630898-C4332992-FFCE-42AF-95B1-58BAB19EB1DC Q35996533-1F6FFDCF-6250-4796-AEFA-37EDA6F67045 Q36262967-5EB7644B-9D35-4095-86A0-F3A24C38D31A Q36331304-B5990032-B2BA-40F1-9472-81D65EBCC2BF Q36375276-2F7956CA-B7EC-44EA-BDBC-DF5EF76B3C2D Q37295497-34FCECA7-9BCC-4B86-8916-502F962931A8 Q37448235-D64B34CB-397C-47E8-A056-BAB9143AA2D1 Q37541872-A597E824-56D8-4FAE-803D-26BD9AC594BB Q37582231-B6D54B4A-CF5D-4422-AF5D-7ED8A354C5B8 Q37688609-66797BAA-60BE-4D84-A065-F53DAA4C583A Q38633650-55D89983-AAA1-46A8-A5A5-243F199364C3 Q38706060-7D13B1B2-E67E-4280-B5A7-EB441AA7B30F Q38812053-1420FA14-C89E-4151-87D1-B54D417A7B47 Q38819547-046149D5-0A10-4532-AA36-1B7A0C132C33 Q38849666-AFF8C796-C433-4E45-8993-DEBE2CF3EA52 Q39275455-18EAD534-6294-452D-8B57-6787E7FD3073 Q41002921-47D71366-1DDC-41BC-A93D-95351640D47D Q41198045-9B760867-9D82-45D1-80A1-3515D440F46E Q45873467-1D578081-794E-4CBB-9F35-33BB454BD2F7 Q47117573-716D3885-12EE-471D-B548-E44D4C6F437E Q47149869-7AAB6100-9DA7-4783-A4E6-D3DE93E49A1F Q48008358-A5996B87-95DC-4D37-964B-554492F3B576 Q49789635-3583F55C-600D-4A73-B3A2-9789F26E9D35 Q51060401-60D90D93-761C-474C-8220-0AE033C7E288 Q52620413-C085055B-DE7D-4185-BCFE-72201A89DF25 Q52919252-9559976D-2882-48A2-AD81-EB7C13180F1C Q58760411-C7CB782C-8771-4903-9EC0-B857D05BA71E

P2860

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

http://www.wikidata.org/entity/Q43653975

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@en

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@nl

type

label

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@en

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@nl

prefLabel

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@en

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@nl

P1433

Q43653975-CE01DE4A-926E-4E75-9578-C05078669BE1

P1476

Q43653975-B02B4139-F20A-4366-80CF-6F8CD64D8195

P2093

Q43653975-17D6930C-E4CB-4C01-A11E-16BC12973F32

Q43653975-4B89AFCC-AA73-4F45-B5BB-969BDA98C3EE

Q43653975-99EB0070-DFFD-44FA-A49E-1C11FECE2F5D

Q43653975-A5AB49E5-97C7-41F0-A6E9-D72FFD583B69

Q43653975-E79694F8-6DF1-4FBE-94D4-B372CE860A26

Q43653975-ECFC277C-56B9-446D-9314-8171458916F7

P2860

Q43653975-0C11BBBE-D58C-4D5F-B440-959E31D44119

Q43653975-10EBE2C3-5495-4C2C-9D1F-7BC80EC961A3

Q43653975-147C0EBC-7F2B-47E4-91F4-B557681EE3AC

Q43653975-17903B23-0B1C-45E7-9BA8-EA57CA1B527B

Q43653975-2263C27B-46C8-487C-B83A-0700D20B1AF6

Q43653975-2D63AA06-47E6-43F6-A11B-75903C564CB8

Q43653975-450CFB0C-8B14-4659-9861-1174492FB550

Q43653975-6866D317-2694-4E88-BC6C-61FEB12F511B

Q43653975-6DBB455B-6327-44E2-B177-D15C99E4A7E9

Q43653975-75826F89-80EC-40DB-9DED-84BF55DB73CC

P2888

Q43653975-ED4EA8B5-14E8-4A10-8FB5-39F18309B2DD

P304

Q43653975-F41C837A-874F-4296-8A57-81B17DAA5E9B

P31

Q43653975-11C3CF7C-40A8-419B-97EC-2EB7DB3D8458

P356

Q43653975-025C1704-6FC1-4F9A-8890-114EB57316D5

P433

Q43653975-CAF3E7CA-A863-47A3-8CAE-9227551B0E7C

P478

Q43653975-22450ABA-D3F7-4C31-A122-AC7D6465E639

P577

Q43653975-D187234D-5F91-4E9C-A563-121830DD63EE

P6179

Q43653975-7DAB841C-1F9D-4468-9527-909D3837AEB1

P698

Q43653975-56BA26BD-74E5-463F-B1EF-5A173ECB0B79

P921

Q43653975-9033F1D3-2139-416F-8125-6298F90EAE8F

P356

S13277-014-2259-4

P1433

P1476

Clinical significance of the low expression of FER1L4 in gastric cancer patients.

@en

P2093

Huajun Shi

http://www.w3.org/2001/XMLSchema#string

Junming Guo

http://www.w3.org/2001/XMLSchema#string

Lin Tan

http://www.w3.org/2001/XMLSchema#string

Shengcan Chen

http://www.w3.org/2001/XMLSchema#string

Yongfu Shao

http://www.w3.org/2001/XMLSchema#string

Zhong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The H19 non-coding RNA is essential for human tumor growth

Treatment of gastric cancer

MEG3 noncoding RNA: a tumor suppressor

Long non-coding RNAs and complex human diseases

Long non-coding RNAs: insights into functions

Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs

RNA maps reveal new RNA classes and a possible function for pervasive transcription

Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer.

Long non-coding RNA in cancer.

Low expression of LOC285194 is associated with poor prognosis in colorectal cancer

P2888

s13277-014-2259-4

P304

9613-9617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-014-2259-4

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005069688

http://www.w3.org/2001/XMLSchema#string

P698

24961353

http://www.w3.org/2001/XMLSchema#string

P921